Published in J Infect Dis on August 01, 1985
Human parvovirus B19. Clin Microbiol Rev (2002) 3.44
Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol (1987) 2.74
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol (1987) 1.77
Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol (1991) 1.75
Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J Virol (2012) 1.64
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.51
Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci U S A (2003) 1.47
Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis (1986) 1.47
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol (1993) 1.45
Erythema infectiosum and pregnancy-related complications. CMAJ (1990) 1.40
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol (1993) 1.24
Two novel parvoviruses in frugivorous New and Old World bats. PLoS One (2011) 1.19
The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol (2009) 1.19
Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol (2001) 1.17
Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia. J Clin Pathol (1988) 1.15
Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol (2002) 1.13
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Acute toxicity of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) in male Sprague-Dawley rats: effects on hepatic oxidative stress, glutathione and metals status. Environ Int (2009) 1.09
Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol (1993) 1.07
Laboratory infection with parvovirus B19. J Clin Pathol (1988) 1.07
Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J Clin Microbiol (1990) 1.07
Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol (1989) 1.06
Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. J Virol (1999) 1.04
Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest (1987) 1.03
Parvovirus B19 infection in human pregnancy. BJOG (2010) 1.02
Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding school. Epidemiol Infect (1989) 1.02
Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry (1998) 1.01
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol (2003) 0.95
Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.94
Parvovirus B19 infection and bone marrow transplantation. Ann Hematol (1992) 0.89
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19. J Virol (2001) 0.87
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol (2002) 0.87
Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry (2002) 0.87
Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i). J Virol (1995) 0.87
Parvovirus B19 outbreak on an adult ward. Epidemiol Infect (1994) 0.86
Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J Virol (2012) 0.86
Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol (2000) 0.86
Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study. BMC Infect Dis (2010) 0.85
Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child (1987) 0.84
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. J Virol (2014) 0.83
High prevelance of human parvovirus infection in patients with malignant tumors. Oncol Lett (2012) 0.80
Hereditary spherocytosis in sisters unmasked by parvovirus infection. Postgrad Med J (1987) 0.80
Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia. Pediatr Blood Cancer (2008) 0.80
Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions. Case Rep Med (2012) 0.80
Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol (2001) 0.80
Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent. BMC Pediatr (2014) 0.80
Simian parvoviruses: biology and implications for research. Comp Med (2008) 0.79
Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS One (2013) 0.79
Rheumatoid arthritis and infection: a population approach. Ann Rheum Dis (1989) 0.78
Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol (2004) 0.78
Infection with Parvovirus B19. Curr Infect Dis Rep (1999) 0.78
A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection. Rheumatol Int (2006) 0.78
Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture. Int J Med Sci (2010) 0.78
Parvovirus B19 infection: fifth disease and more. CMAJ (2005) 0.78
Secondary symptomatic parvovirus B19 infection in a healthy adult. J Gen Intern Med (2007) 0.77
Association between human parvovirus B19 infection and arthritis. Ann Rheum Dis (1995) 0.77
Parvovirus B19 - Revised. Transfus Med Hemother (2010) 0.77
Evaluation of a real-time PCR assay using the LightCycler system for detection of parvovirus B19 DNA. J Clin Microbiol (2004) 0.77
Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran (2015) 0.76
Parvovirus B19 in anemic liver transplant recipients. Clin Diagn Lab Immunol (1996) 0.76
Neonatal meningitis with human parvovirus B19 infection. Arch Dis Child Fetal Neonatal Ed (1995) 0.76
Transient pancytopenia associated with parvovirus infection in paroxysmal nocturnal haemoglobinuria. Postgrad Med J (1987) 0.76
Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clin Diagn Lab Immunol (1996) 0.76
Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature. BMC Res Notes (2014) 0.75
Imaging of the embryonic and fetal central nervous system. Facts Views Vis Obgyn (2009) 0.75
Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure. Mem Inst Oswaldo Cruz (2016) 0.75
Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family. Iran J Med Sci (2015) 0.75
Human parvovirus B19 infection within a family and risk for pregnant women. Epidemiol Infect (1996) 0.75
Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol (1996) 0.75
Parvovirus infection and anaemia in a patient with AIDS: case report. Genitourin Med (1990) 0.75
Three Adult Cases of HPV-B19 Infection with Concomitant Leukopenia and Low Platelet Counts. Clin Med Insights Case Rep (2015) 0.75
Parvovirus infection mimicking systemic lupus erythematosus. CMAJ (2013) 0.75
Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseases. Ann Rheum Dis (2006) 0.75
Three cases of illness during a drug trial in healthy volunteers. Br Med J (Clin Res Ed) (1987) 0.75
Pure Red Cell Aplasia due to B19 Parvovirus Infection after Autologous Stem Cell Transplantation. Case Rep Transplant (2011) 0.75
Similarities in nucleotide sequence between serum and faecal human parvovirus DNA. Epidemiol Infect (1990) 0.75
Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection. Case Rep Obstet Gynecol (2017) 0.75
Human Parvovirus B19 in Children with Sickle Cell Disease; Poking the Spleen. Oman Med J (2017) 0.75
Prolonged anemia by superinfection of parvovirus B19 in a boy with enterohemorrhagic Escherichia coli O157-associated hemolytic uremic syndrome. Eur J Pediatr (2008) 0.75
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
The in vivo replication origin of the yeast 2 microns plasmid. Cell (1987) 6.81
Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75
Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
General practitioner obstetrics in Bradford. BMJ (1990) 4.28
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol (1999) 3.62
Nerve-induced and spontaneous redistribution of acetylcholine receptors on cultured muscle cells. J Physiol (1977) 3.45
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J (1974) 3.42
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
Simple, rapid method for assay of aminoglycoside antibiotics. Lancet (1971) 3.35
Close association of a DNA replication origin and an ARS element on chromosome III of the yeast, Saccharomyces cerevisiae. Nucleic Acids Res (1988) 3.21
Letter: Viruses and gastroenteritis in infants. Lancet (1975) 3.13
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol (2000) 2.73
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Effects of innervation on the distribution of acetylcholine receptors on cultured muscle cells. J Physiol (1977) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Evidence suggesting that the ARS elements associated with silencers of the yeast mating-type locus HML do not function as chromosomal DNA replication origins. Mol Cell Biol (1991) 2.56
Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54
Human parvovirus B19. BMJ (1994) 2.53
The detection of specific IgM antibodies following infection with rubella virus. J Clin Pathol (1975) 2.49
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
A respiratory virus study in Great Britain: review and evaluation. Prog Med Virol (1969) 2.34
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
Rubella epidemiology in South East England. J Hyg (Lond) (1986) 2.28
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Fluorescent staining of acetylcholine receptors in vertebrate skeletal muscle. J Physiol (1974) 2.20
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol (1997) 2.17
Outcome of asymptomatic infection with rubella virus during pregnancy. J Hyg (Lond) (1981) 2.15
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
The human parvovirus. Brief review. Arch Virol (1984) 2.05
Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet (1983) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey. J Hyg (Lond) (1978) 1.96
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
Therapeutic implications of interaction of gentamicin and penicillins. Lancet (1971) 1.85
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer (1976) 1.85
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med (1985) 1.77
Persistence of specific IgM after natural infection with rubella virus. Lancet (1975) 1.74
A simple, inexpensive gel filtration technique for use in diagnostic serology. J Clin Pathol (1973) 1.72
A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71
Human parvovirus infection in homozygous sickle cell disease. Lancet (1993) 1.71
Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed) (1984) 1.70
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66